Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ ― | $ 2.75B | $ 3.31B | $ 3.09B | $ 2.75B |
Total Assets | - | $ 43.41B | $ 44.40B | $ 38.15B | $ 36.70B |
Total Debt | $ ― | $ 11.53B | $ 11.66B | $ 7.76B | $ 6.78B |
Net Debt | $ ― | $ 8.78B | $ 8.35B | $ 4.67B | $ 4.03B |
Total Liabilities | - | $ 15.46B | $ 17.32B | $ 11.54B | $ 10.87B |
Stockholders Equity | $ ― | $ 25.03B | $ 24.17B | $ 23.68B | $ 22.98B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |